Biocon (BIOCON) Share Price Falls 2.19% Today as Stock Declines to Rs 385.50

Published:   24 September 2026 at 3:19:20 PM IST

Biocon slipped to Rs 385.50, down 2.19% today, with market capitalisation at Rs 63,435.84 crore.

Biocon Share Price fell in today’s trade, with the stock closing at Rs 385.50 after a 2.19% decline from the previous close of Rs 394.15. The company’s market capitalisation stands at Rs 63,435.84 crore, placing it in the Large Cap category. For investors tracking Biocon Share Price Today, the move is notable because the day’s low matched the closing price, while the stock traded between Rs 392.40 and Rs 394.55 before easing to Rs 385.50. The supplied data confirms the price event, but it does not establish a company-specific catalyst. Biocon Stock News therefore centres on the observed share price fall, the valuation profile and the sector comparison rather than on any unverified trigger.

At Univest, this is best read as a factual market update: Biocon Share Price Today reflected a clear intraday decline, and the move can be examined through price action, fundamentals, sector benchmarks and peer positioning. The article below explains what changed in the session, what the key numbers say and what investors may want to monitor next.

Biocon (BIOCON) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 385.5
Previous Close	Rs 394.15
Today's Move	-Rs 8.65 (-2.19%)
Open	Rs 392.4
High	Rs 394.55
Low	Rs 385.5
Turnover	Rs 2.48 crore
Market Capitalisation	Rs 63,435.84 crore
Market Cap Category	Large Cap

Biocon Share Price Today moved lower by Rs 8.65, or 2.19%, to Rs 385.50. The session opened at Rs 392.40, touched a high of Rs 394.55 and a low of Rs 385.50. That means the stock ended exactly at the day’s low, after trading below the previous close of Rs 394.15 throughout the session. The turnover was Rs 2.48 crore, which is the exact traded-value figure supplied for the day.

The price fall needs to be read in the context of the broader share price setup rather than as a standalone event. Biocon Share Price Today is now below the previous close, below the opening print and below the day’s high, which shows that the session ended with a weaker closing position than the morning level. For investors following Biocon Share Price, the immediate question is how the current level compares with larger reference points across the stock’s market history and valuation base. The company remains a Large Cap stock with a market capitalisation of Rs 63,435.84 crore, so today’s decline is being recorded on a sizable listed franchise. Biocon Stock News for the day is therefore about a measurable price fall, not about an inferred reason. Biocon Share Price will remain a key search term for anyone comparing intraday moves, market-cap context and the next session’s opening tone.

Biocon (BIOCON) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 63,435.84 crore
P/E Ratio	129.69x
P/B Ratio	1.89x
ROE	1.35%
ROCE	3.26%
EPS	Rs 3.04
Book Value Per Share	Rs 208.53
Dividend Yield	0.13%

EPS stands at Rs 3.04, which shows earnings attributable to each share. Book value is Rs 208.53 per share, which shows the accounting net worth behind each share. Dividend yield is 0.13%, which is the supplied historical payout measure relative to the current price. In simple terms, Biocon Share Price is supported by a business with a substantial listed value base, but the reported P/E is much higher than many healthcare peers and the ROE and ROCE figures are modest against the same group. Univest readers often use this mix of valuation and profitability data to understand why Biocon Share Price Today can attract attention even in a weak session. The numbers do not explain today’s move, but they do frame Biocon Stock News in a broader fundamental context. Biocon Share Price and Biocon Fundamental Analysis therefore remain closely linked for investors comparing pricing, earnings and return metrics.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	129.69x
Benchmark Median P/E	31.9x
Benchmark Average P/E	50.01x
Benchmark P/E Range	3.48x to 762.66x
Company P/B Ratio	1.89x
Benchmark Median P/B	3x
Benchmark Average P/B	4.38x
Company ROE	1.35%
Benchmark Median ROE	11.7%
Benchmark Average ROE	10.65%
Company ROCE	3.26%
Benchmark Median ROCE	13.46%
Benchmark Average ROCE	13.26%
Company Market Capitalisation	Rs 63,435.84 crore
Benchmark Median Market Cap	Rs 761.61 crore
Benchmark Average Market Cap	Rs 14,299.75 crore

Biocon operates in Healthcare, within the Pharmaceuticals & Drugs industry. The supplied benchmark covers the same industry and includes 200 companies, which makes the comparison broad enough to place Biocon’s numbers in a relevant sector context. Biocon Share Price should be read against this backdrop because its valuation and return ratios sit meaningfully apart from the benchmark medians and averages.

The company’s P/E of 129.69 is well above the industry median of 31.9 and the average of 50.01. Its P/B of 1.89 is below the industry median of 3 and the average of 4.38. ROE at 1.35 is below the industry median of 11.7 and the average of 10.65, while ROCE at 3.26 is also below the industry median of 13.46 and the average of 13.26. The market-cap comparison is also useful: Biocon’s Rs 63,435.84 crore is far above the industry median of Rs 761.61 crore and below the industry average of Rs 14,299.75 crore? On the supplied benchmark scope, the market-cap average is distorted upward by large names, which is why direct peer comparison is also necessary. For Biocon Share Price Today, the key takeaway is that the stock is priced and valued within a sector that contains both low-multiple and premium-multiple names, but Biocon’s own P/E is at the higher end of the supplied set. Biocon Stock News therefore sits in a sector discussion about valuation spread, profitability and market-cap scale rather than a broad industry call. Univest readers tracking Biocon Share Price can use this sector lens to compare the company’s current pricing with its broader healthcare universe.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,42,437.37	37	5.17	14.85	19.11
Divi's Laboratories	DIVISLAB	2,48,053.84	87.1	14.42	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,89,841.6	86.85	21.1	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,15,810.19	25.85	4.33	19.69	21.39
Cipla	CIPLA	1,11,565.25	33.08	3.17	11.83	16

Biocon Share Price can be compared with listed healthcare peers to understand where the stock sits within the same industry set. Among the supplied peers, Biocon’s market capitalisation of Rs 63,435.84 crore is smaller than Sun Pharmaceutical Industries at Rs 4,42,437.37 crore, Divi’s Laboratories at Rs 2,48,053.84 crore and Torrent Pharmaceuticals at Rs 1,89,841.60 crore, but larger than Zydus Lifesciences at Rs 1,15,810.19 crore and Cipla at Rs 1,11,565.25 crore.

On valuation, Biocon’s P/E of 129.69 is above Sun Pharma at 37, Zydus Lifesciences at 25.85, Cipla at 33.08 and Dr. Reddy’s Laboratories at 31.35, while it is below Divi’s Laboratories at 87.1, Torrent Pharmaceuticals at 86.85 and Laurus Labs at 100.55. Biocon’s P/B of 1.89 is below the P/B values shown for all the listed peers in the supplied peer set. Its ROE of 1.35 and ROCE of 3.26 are also below every peer shown in the comparison set. For Biocon Share Price Today, this means the move should be viewed alongside a valuation profile that differs materially from the peer group. Biocon Stock News is therefore not only about the day’s decline; it is also about how the company’s earnings and capital returns compare with the listed healthcare names in the same industry.

Why Investors Are Watching Biocon

• Biocon Share Price declined 2.19% today to Rs 385.50, after opening at Rs 392.40 and touching a high of Rs 394.55.
• The stock closed at its day’s low of Rs 385.50, below the previous close of Rs 394.15.
• Biocon’s market capitalisation stands at Rs 63,435.84 crore, and the company is classified as Large Cap.
• The stock’s P/E ratio is 129.69, while ROE is 1.35 and ROCE is 3.26.
• Biocon Share Price is also being compared with peers such as Sun Pharma, Divi’s Laboratories, Torrent Pharma, Zydus Lifesciences and Cipla.

About Biocon

Biocon is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The company sits within a broad listed peer group that includes major Indian pharmaceutical names. For readers tracking Biocon Share Price, this sector classification matters because Biocon Stock News is often compared with other healthcare counters that share similar market benchmarks, valuation multiples and profitability measures.

The supplied data does not add business-segment, product or revenue-mix detail, so the company profile here is intentionally factual and to the verified sector and industry context. Even so, Biocon Share Price Today remains relevant because the company’s market capitalisation, valuation ratio and return metrics place it in a distinct position within the industry set. Univest users often review Biocon Share Price alongside the company’s financial ratios and peer comparison to understand the stock’s current market context.

Track Biocon Share Price on Univest

Use Biocon (BIOCON) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.

Track Biocon Share Price on Univest for live price updates, key ratios, market capitalisation, shareholding pattern, sector context and 52-week levels. Univest also brings together Biocon Stock News, Biocon Share Price Today and Biocon Share Price Update in one place for quick review.

Frequently Asked Questions

Why is Biocon Share Price falling today?

Ans.  Biocon Share Price fell 2.19% to Rs 385.50 today. The supplied data confirms the decline, but it does not establish a company-specific catalyst, so the move should be read as a verified price event only.

What is Biocon Share Price today?

Ans.  Biocon Share Price today is Rs 385.50. The stock declined from the previous close of Rs 394.15, and the day’s high and low were Rs 394.55 and Rs 385.50 respectively.

What is Biocon’s market capitalisation?

Ans.  Biocon’s market capitalisation is Rs 63,435.84 crore. The company is classified as Large Cap in the supplied data, which helps frame today’s price fall in a company-size context. The company operates in the Healthcare sector.

What does Biocon’s valuation look like?

Ans.  Biocon trades at a P/E of 129.69 and a P/B of 1.89. EPS is Rs 3.04, book value is Rs 208.53 and dividend yield is 0.13%, which together frame the valuation picture.

How does Biocon compare with healthcare peers?

Ans.  Biocon’s P/E is higher than several peers such as Sun Pharma, Cipla and Zydus Lifesciences, while its P/B, ROE and ROCE are below the peer values shown in the supplied comparison set.

What do Biocon’s ROE and ROCE show?

Ans.  Biocon’s ROE is 1.35 and ROCE is 3.26. These figures measure shareholder return and capital efficiency, and they sit below the benchmark medians supplied for the same industry. ROE stands at 1.35%.

What should investors track next in Biocon Share Price?

Ans.  Investors can track the next day’s opening price, continuation or reversal of today’s decline, and any change in valuation relative to the healthcare peer set. Univest provides these updates in one place.